12/10/2026
The Durham Genome Centre in Lanchester is leading an International GLP-1 Research Study. Right here on your doorstep!
We have joined forces with partners in Japan, Portugal and Scotland to launch an innovative new study investigating whether Coenzyme Q10 (CoQ10) supplementation can benefit people using GLP-1 weight management medications.
The study will recruit participants currently prescribed a GLP-1 medication and aims to generate valuable real-world evidence on the potential role of CoQ10 in supporting wellbeing during weight loss. Researchers will examine whether CoQ10 may help support energy levels, metabolic health and overall wellbeing in individuals using GLP-1 therapies.
For more information and check eligibility, visit www.enrol.studysetgo.com/zest
You can also read a little more about the Research Study on the recently published "Business Durham" article: https://www.businessdurham.co.uk/post/lanchester-firm-leads-international-glp-1-research-study
Lanchester Firm Leads International GLP-1 Research Study